Results 201 to 210 of about 81,406 (283)

Targeted Therapies for Each Subtype of Breast Cancer. [PDF]

MedComm (2020)
Liu A, Peng P, Zhu Y, Fei Q, Liu W, Zhang S.   +5 more
europepmc   +1 more source

CircNSD2 promotes metastasis and immune escape by increasing the USP10/SRSF6-mediated alternative splicing of TPM1 in TNBC. [PDF]

Mol Cancer
Sun Y, Li Y, Niu T, Wang Z, Yang J, He Y, Liang Y, Chen X, Chen T, Wang L, Chen B, Zhao W, Kong X, Yang Q.   +13 more
europepmc   +1 more source

A functional genomic screen in vivo identifies CEACAM5 as a clinically relevant driver of breast cancer metastasis [PDF]

, 2018
Edwards, John R., Schlosberg, Christopher   +1 more
core   +1 more source

A phase 1 study of ASTX727 plus talazoparib in patients with triple‐negative or hormone resistant/HER2‐negative metastatic breast cancer

Cancer, Volume 132, Issue 8, 15 April 2026.
Abstract Background Poly(adenosine diphosphate ribose) polymerase (PARP) is recruited to DNA damage sites along with epigenetic factors such as DNA methyltransferase 1 (DNMT1). Inhibitors of DNMT modulate reactive oxygen species (ROS)‐cyclic adenosine monophosphate (cAMP)/Protein Kinase A signaling and induce a “BRCAness phenotype” that further ...
Kathy D. Miller, Alexandra Thomas, Sandra Althouse, Yong Zang, Erin Conder, Ryan Burgos, Bryan P. Schneider, Tarah Ballinger, Emily Douglas, Katherine Ansley, H. Josh Jang, Woonbok Chung, Jean‐Pierre Issa, Kenneth P. Nephew, Feyruz V. Rassool   +14 more
wiley   +1 more source

Preclinical Comparison of ¹⁸F-Labeled Amino Acids Targeting Different Transporter Systems for PET Imaging of Triple-Negative Breast Cancer. [PDF]

J Nucl Med
Akca U, Song PN, Devalankar D, Yasui N, Sorace AG, McConathy J.   +5 more
europepmc   +1 more source

Integrating bulk, single-cell, and spatial transcriptomics to identify a novel pyroptosis-related gene signature for predicting prognosis and tumor immune landscape in triple-negative breast cancer. [PDF]

Front Immunol
Xiang L, Rao J, Ma A, Zhang Y, Li C, Xie T, Xue H, Chen Z, Liu T, Yuan J, Yan H.   +10 more
europepmc   +1 more source

MUCL1 in triple-negative breast cancer: a novel marker associated with the luminal androgen receptor subtype. [PDF]

Breast Cancer Res
Klaus FL, Kitzke I, Klein E, Mogler C, Muckenhuber A.   +4 more
europepmc   +1 more source

Association of lncRNA AGAP11 with prognosis and malignant progression in triple-negative breast cancer. [PDF]

Discov Oncol
Fu G, Song J, Wu W, Zhang X, Zhong D.
europepmc   +1 more source

Translational selenium nanoparticles trigger apoptosis in triple-negative breast cancer cells through the MAPKs/Bcl2 pathway. [PDF]

Bioact Mater
Zou B, Li S, Luk KH, Dong X, Chun-Him Lai N, Cheng WY, Liu G, Wong KH, Chen T.   +8 more
europepmc   +1 more source